Germany-based BioVision hopes to find and identify clinically relevant peptides, the company said.
Financial terms of the agreement were not disclosed.
Germany-based BioVision hopes to find and identify clinically relevant peptides, the company said.
Financial terms of the agreement were not disclosed.